Silver Brian M.'s Form 4 filing
TScan Therapeutics, Inc. (TCRX) · filed Dec 29, 2022
- Accession no.
- 0000899243-22-039506
- Filed
- Dec 29, 2022
- Trade date
- Dec 27-28, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $9.19K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silver Brian M.CIK 0001860597 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | Voting Common Stock | PPurchaseAcquired | +2,842 | $1.50 | +$4,263 | 29,727 | Direct | |
| Dec 28, 2022 | Voting Common Stock | PPurchaseAcquired | +3,158 | $1.56 | +$4,926.48 | 32,885 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.